HomeCompareGIVXF vs MRK

GIVXF vs MRK: Dividend Comparison 2026

GIVXF yields 186.13% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GIVXF wins by $15.5K in total portfolio value
10 years
GIVXF
GIVXF
● Live price
186.13%
Share price
$1.07
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.3K
Annual income
$66.75
Full GIVXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GIVXF vs MRK

📍 GIVXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGIVXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GIVXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GIVXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GIVXF
Annual income on $10K today (after 15% tax)
$15,821.31/yr
After 10yr DRIP, annual income (after tax)
$56.74/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,271.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GIVXF + MRK for your $10,000?

GIVXF: 50%MRK: 50%
100% MRK50/50100% GIVXF
Portfolio after 10yr
$64.5K
Annual income
$4,932.45/yr
Blended yield
7.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GIVXF
No analyst data
Altman Z
6.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GIVXF buys
0
MRK buys
0
No recent congressional trades found for GIVXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGIVXFMRK
Forward yield186.13%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$72.3K$56.8K
Annual income after 10y$66.75$9,798.13
Total dividends collected$31.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GIVXF vs MRK ($10,000, DRIP)

YearGIVXF PortfolioGIVXF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,007$9,306.65$11,206$366.19+$8.8KGIVXF
2$30,108$8,700.70$12,650$502.35+$17.5KGIVXF
3$38,334$6,118.51$14,407$694.19+$23.9KGIVXF
4$44,658$3,640.28$16,585$967.82+$28.1KGIVXF
5$49,765$1,981.68$19,342$1,363.89+$30.4KGIVXF
6$54,281$1,031.93$22,913$1,947.19+$31.4KGIVXF
7$58,606$525.96$27,662$2,823.89+$30.9KGIVXF
8$62,974$265.36$34,159$4,173.35+$28.8KGIVXF
9$67,516$133.24$43,337$6,308.80+$24.2KGIVXF
10$72,308$66.75$56,776$9,798.13+$15.5KGIVXF

GIVXF vs MRK: Complete Analysis 2026

GIVXFStock

Givex Information Technology Group Limited provides omni-channel gift cards, loyalty programs, data analytics, stored value tickets, payment processing, and cloud-based Point of Sale (POS) solutions in Canada, the United States, Australia, the United Kingdom, and internationally. It offers gift card processing, gift card production and fulfillment, mobile wallet solutions, and personalized cards; POS systems; analytics solutions; Uptix, a ticketing solution; self-ordering kiosks; and GivexPay, a payment solution. The company also operates CWS, an interactive gift card Website; loyalty programs; and Givex Go, a mobile application. In addition, it offers recycled PVC cards, PLA cards, paper stock cards, soy-based inks for gift card carriers, recycled material for gift card carriers, and shredding and recycling of deactivated cards. The company was founded in 1999 and is headquartered in Toronto, Canada.

Full GIVXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GIVXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GIVXF vs SCHDGIVXF vs JEPIGIVXF vs OGIVXF vs KOGIVXF vs MAINGIVXF vs JNJGIVXF vs ABBVGIVXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.